Showing results (81-90 of 351) with videos related to

Sort By:
Pageof 36
The Lancet. Respiratory Medicine|December 11, 2013
Efficacy and safety of once-daily QVA149 compared with twice-daily salmeterol-fluticasone in patients with chronic obstructive pulmonary disease (ILLUMINATE): a randomised, double-blind, parallel group studyClaus F Vogelmeier, Eric D Bateman, John Pallante, et al.
Respiration; International Review of Thoracic Diseases|September 5, 2015
Effect of a Three-Week Inpatient Rehabilitation Program on 544 Consecutive Patients with Very Severe COPD: A Retrospective AnalysisTimm Greulich, Andreas Rembert Koczulla, Christoph Nell, et al.
Respiratory Research|October 31, 2013
Characterisation of exacerbation risk and exacerbator phenotypes in the POET-COPD trialKai M Beeh, Thomas Glaab, Susanne Stowasser, et al.
Respiratory Medicine|December 27, 2023
Impact of COPD on mortality: An 8-year observational retrospective healthcare claims database cohort studyClaus F Vogelmeier, Felix W Friedrich, Patrick Timpel, et al.
Plos One|October 30, 2019
Increased rate of FEV1 decline in HIV patients despite effective treatment with HAARTGloria Samperiz, Francisco Fanjul, Jose Luis Valera, et al.
International Journal of Chronic Obstructive Pulmonary Disease|October 30, 2020
A Non-Interventional Study of Tiotropium/Olodaterol versus Any Triple Combination Therapy for Chronic Obstructive Pulmonary Disease: The EVELUT® Study ProtocolRoland Buhl, Michael Dreher, Stephanie Korn, et al.
The New England Journal of Medicine|May 22, 2019
Benralizumab for the Prevention of COPD ExacerbationsGerard J Criner, Bartolome R Celli, Christopher E Brightling, et al.
Respiratory Research|April 17, 2021
Prevalence of overuse of short-acting beta-2 agonists (SABA) and associated factors among patients with asthma in GermanyHeinrich Worth, Carl-Peter Criée, Claus F Vogelmeier, et al.
Respiratory Medicine|August 2, 2015
Airflow limitation in COPD is associated with increased left ventricular wall stress in coincident heart failurePeter Alter, Kirsten van de Sand, Christoph Nell, et al.
The Lancet. Respiratory Medicine|January 28, 2014
Effect of ADRB2 polymorphisms on the efficacy of salmeterol and tiotropium in preventing COPD exacerbations: a prespecified substudy of the POET-COPD trialKlaus F Rabe, Leonardo M Fabbri, Elliot Israel, et al.
Pageof 36